Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Lorus expands Canadian prostate cancer study of GTI-2501 and docetaxel

July 12, 2004

Enrollment open at European sites in CoFactor phase II study

July 12, 2004

Allergan files INDs for PEP-005 Topical

July 12, 2004

First clinical evidence of antitumor effects induced by taurolidine in glioblastoma

July 9, 2004

ArQule describes lapachone analogues

July 9, 2004

Tyrosine kinase inhibitors patented by Merck KGaA

July 9, 2004

Abbott and Celera form cancer therapeutics collaboration

July 9, 2004

GOG submits IND for Xyotax study in ovarian cancer

July 9, 2004

U.S. phase I trial of Exherin cleared to begin

July 9, 2004

Chiron acquires Sagres Discovery

July 9, 2004

Popular Stories

News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...
Plasticity, properly parsed, provides psychiatric platform
BioWorld
If Benjamin Braddock, of The Graduate fame, were a young neuroscientist in the 21st century instead of a liberal arts graduate in 1967, the advice he received...